Oppenheimer analyst Justin Kim downgrades BioCryst Pharmaceuticals (NASDAQ:BCRX) from Outperform to Perform.
What’s Going On With C3.ai Stock Today?
C3.ai, Inc. (NYSE: AI) shares are trading lower Wednesday following comments from Fed Chair Jerome Powell suggesting further rate hikes may be needed to fight inflation, despite the June pause.